460
Participants
Start Date
August 31, 2004
Primary Completion Date
June 30, 2005
Study Completion Date
June 30, 2005
UK-390,957
Pfizer Investigational Site, Bondi Junction
Pfizer Investigational Site, St Leonards
Pfizer Investigational Site, Spring Hill
Pfizer Investigational Site, Adelaide
Pfizer Investigational Site, Malvern
Pfizer Investigational Site, Nedlands
Pfizer Investigational Site, Mistelbach
Pfizer Investigational Site, Salzburg
Pfizer Investigational Site, Edmonton
Pfizer Investigational Site, Victoria
Pfizer Investigational Site, London
Pfizer Investigational Site, Oakville
Pfizer Investigational Site, Toronto
Pfizer Investigational Site, Montréal
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Brno
Pfizer Investigational Site, Hradec Králové
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Le Kremlin-Bicêtre
Pfizer Investigational Site, Lyon
Pfizer Investigational Site, Munich
Pfizer Investigational Site, Hamburg
Pfizer Investigational Site, Hanover
Pfizer Investigational Site, München
Pfizer Investigational Site, Beersheba
Pfizer Investigational Site, Haifa
Pfizer Investigational Site, Jerusalem
Pfizer Investigational Site, Tel Aviv
Pfizer Investigational Site, Tel Litwinsky
Pfizer Investigational Site, Milan
Pfizer Investigational Site, Roma
Pfizer Investigational Site, Nijmegen
Pfizer Investigational Site, The Hague
Pfizer Investigational Site, Bodø
Pfizer Investigational Site, Moelv
Pfizer Investigational Site, Oslo
Pfizer Investigational Site, Bialystok
Pfizer Investigational Site, Kielce
Pfizer Investigational Site, Mysłowice
Pfizer Investigational Site, Warsaw
Pfizer Investigational Site, Barcelona
Pfizer Investigational Site, Sabadell
Pfizer Investigational Site, Madrid
Pfizer Investigational Site, Málaga
Pfizer Investigational Site, Skövde
Pfizer Investigational Site, Stockholm
Pfizer Investigational Site, Balcali
Pfizer Investigational Site, Samanpazarı
Pfizer Investigational Site, Balçova
Lead Sponsor
Pfizer
INDUSTRY